GLP-1 RAs and cardiovascular protection for your type 2 diabetes patient

In this CPD-accredited report, experts review the latest findings for the cardiovascular complications of diabetes.

You will learn:

Current evidence on the cardiovascular protection benefits of GLP-1 RA therapy
In daily clinical practice, the T2DM patient’s cardiovascular risk should be addressed as early as possible.

To access this module, please register or login: